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The cytolethal distending toxins (CDTs) comprise a family of intracellular-acting bacterial
protein toxins whose actions upon eukaryotic cells result in several consequences, the
most characteristic of which is the induction of G2/M cell cycle arrest. Most CDTs are
hetero-tripartite assemblies of CdtA, CdtB, and CdtC, with CdtB required for CDT-mediated
cell cycle arrest. Several lines of evidence indicate that CdtA and CdtC are required for the
optimal intracellular activity of CdtB, although the exact functional roles of CdtA and CdtC
remain poorly understood. The genes encoding the CDTs have been identified in a diverse
array of Gram-negative pathogenic bacteria. More recently, the genes encoding several
CdtB subunits have been associated with alternatively linked subunits resembling the
B-subunits of pertussis toxin. Although the CDTs are generally considered to all function
as bacterial genotoxins, the extent to which individual members of the CDTs employ
similar mechanisms of cell surface binding, uptake, and trafficking within sensitive cells
is poorly understood. Recently, data have begun to emerge suggesting differences in the
molecular basis by which individual CDTs interact with and enter host cells, suggesting
the possibility that CDTs possess properties reflecting the specific niches idiosyncratic
to those CDT bacterial pathogens that produce them. The extent to which functional
differences between individual CDTs reflect the specific requirements for intoxicating
cells and tissues within the diverse range of host microenvironments colonized by
CDT-producing pathogenic bacteria remains to be experimentally explored.
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PREFACE
Pathogenic bacteria have acquired attributes that promote adap-
tation to the specific and often diverse environments encountered
within the host. Successful pathogens often actively alter, or
remodel, host cells and tissues in order to create a more suitable
niche for colonization, often through the direct action of bacterial
protein toxins and effectors (Blanke, 2006).
A diverse group of Gram-negative pathogenic bacteria target
and modulate the eukaryotic cell cycle through the action of the
cytolethal distending toxins (CDTs). Several lines of evidence sup-
port the idea that CDTs functions as genotoxins by inducing DNA
lesions that ultimately result in cell cycle arrest and cytotoxic-
ity. Current models for both the mechanisms underlying CDT
action, as well as the cellular responses to intoxication, have been
derived primarily from the study of CDTs from just several toxin-
producing species of pathogenic bacteria. However, the discovery
of broad carriage of the genes encoding CDTs across many Gram-
negative bacteria, as well as the sequence variance between CDTs
challenges the notion that individual members within this broad
family of these toxins each bind, enter, and deliver their toxic
moiety into host cells by an identical mechanism.
DISCOVERY OF THE CDTs
The CDTs were discovered approximately 25 years ago as heat
labile factors within culture filtrates of enterotoxigenic E. coli
(Johnson and Lior, 1988a) and Campylobacter spp. (Johnson
and Lior, 1988b) that induced dramatic and progressive disten-
tion of many, but not all, mammalian cell lines. In the decades
that have followed their initial discovery, CDTs have been asso-
ciated with Gram-negative pathogenic bacteria that occupy a
diverse array of host niches, including the urogenital tract and
the oral cavity. A variety of Gram-negative pathogenic bacte-
ria produce CDTs, includingAggregatobacter actinomycetemcomi-
tans (Aa-CDT), Campylobacter jejuni (Cj-CDT), Escherichia coli
(Ec-CDT), Haemophilus ducreyi (Hd-CDT), Helicobacter hepati-
cus (Hh-CDT), and Shigella dysenteria (Sd-CDT). But how widely
found are the CDTs?
EVOLUTION OF THE EXPANDING FAMILY OF CDTs
From the mid 1990s and into the early 2000s, the meth-
ods for identifying CDT-producing Gram-negative pathogenic
bacteria morphed from primarily phenotypic observations of
toxin-mediated distention of cultured mammalian cells to geno-
typing strains for the presence of the genes encoding CDT. The
true molecular nature of CDT was revealed from sequencing
CDT-encoding regions from enteropathogenic E. coli (EPEC)
(Scott and Kaper, 1994) and enterotoxigenic E. coli (ETEC)
(Pickett et al., 1994), which revealed the presence of three open
reading frames (designated cdtA, cdtB, and cdtC) organized
within a 3-gene operon (Figure 1). Although, widely conserved
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FIGURE 1 | Three independent proteins are required to make CDT
holotoxin.Most of the known CDTs are composed of CdtA, CdtB, and CdtC,
with some exceptions like S. typhi where PltA and PltB make holotoxin with
CdtB. All CdtAs contain an aromatic patch, demonstrated to be important in
binding to the surface of mammalian cells. CdtBs are most conserved
amongst three proteins, and are the catalytic subunit of the toxin carrying
conserved metal coordinating residues, DNase catalytic residues, and
residues homologous to DNA contacting residues of DNase I. CdtCs contain
conserved residues believed to be important in formation of a cell surface
binding groove. The scale bar represents primary sequence length equivalent
to 200 residues. CDT, Cytolethal Distending Toxin; Plt, Pertussis like toxin.
Individual genuses and species are abbreviated as follows: Ec, Escherichia
coli; Cj, Campylobacter jejuni; Aa, Aggregatobacter actinomycetemcomitans;
Cl, Campylobacter lari; Ea, Escherichia albertii; Hp, Haemophilus parasuis;
Cc, Campylobacter coli; Hd, Haemophilus ducreyi; Cu, Campylobacter
upsaliensis; Hh, Helicobacter hepaticus; Sb, Shigella boydii; Cf,
Campylobacter fetus; Hp, Helicobacter pullorum; St, Salmonella typhi; Hb,
Helicobacter bilis; Hc, Helicobacter cinaedi; Hw, Helicobacter winghamensis;
Pa, Providencia alcalifaciens; Se, Salmonella enterica; Sd, Shigella
dysenteriae.
among CDT-producing pathogens, exceptions to the overall
cdtA/cdtB/cdtC gene structure have been identified. Most notably,
a distinct CDT with cdtB conserved, but having cdtA and cdtC
substituted with genes encoding two homologs of the pertussis
toxin (Figure 2) has been described in Salmonella enterica serovar
Typhi (S. typhi) (Spanò et al., 2008), and will be considered
separately below.
PHYLOGENETIC ANALYSIS OF CDT SUBFAMILIES
To obtain insights into the evolutionary and functional relation-
ships between the proteins encoded by these genes, we exam-
ined the phylogenetic relationships between the CDT family
members using an expanded set of sequences from theNCBI non-
redundant protein database, which currently (accessed February
23, 2012) contains 690, 584, and 695 protein sequences annotated
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FIGURE 2 | Amino acid maximum likelihood phylogenies of the three
subunits of CDT. Sequences were extracted from the NCBI non-redundant
protein database using BLAST with the criteria that sequences have at least
30% identity and 50% coverage against a known set of CDT subunit
sequences from H. ducreyi, A. actinomycetemcomitans, E. coli, E. albertii,
S. dysenteriae, S. enterica, C. jejuni, and H. bilus. Sequences below these
threshold cut-offs were too divergent to be reliably aligned for phylogenetic
analyses. Multiple identical sequences from the same species were reduced
to unique representatives. The sequences were aligned using a combination
of MAFFT and MUSCLE. Phylogenies were inferred using PhyML according
to the LG substitution matrix. Clades are colored according to the dominant
genus with likely horizontal gene transfer candidates in black. Clades
dominated by sequences from a single species are labeled once and distinct
clades of sequences from the same species are numbered.
to encode CdtA, CdtB, and CdtC, respectively. Phylogenetic anal-
ysis revealed a high level of diversity among individual cdt genes
(Figure 2), consistent with a previous published phylogenetic
analysis (Degnan and Moran, 2008). Collectively, 32 species of
bacteria and 2 bacteriophages were identified to have genes anno-
tated to encode at least one CDT subunit. Interestingly, the cdt
genes identified from the current database were restricted to
members of the γ-Proteobacteria and ε-Proteobacteria, consistent
with earlier reported results (Degnan and Moran, 2008).
The individual phylogenies for each subunit of CDT resolve
similar relationships indicating that evolution has occurred
largely in the form of vertical descent but is punctuated with occa-
sional instances of horizontal gene transfer adding complexity to
the evolutionary history (Ochman et al., 2000). The presence of
Frontiers in Cellular and Infection Microbiology www.frontiersin.org October 2012 | Volume 2 | Article 124 | 3
Gargi et al. Diversity among the CDTs
CDT subunits on bacteriophage further supports this proposal of
lateral gene transfer events.
Examination of the phylogenies (Figure 2) reveals that the
species of the genus Yersinia possess the most unique sequence
types of CDT found in the NCBI databases. The branch leading
to a Yersinia species was the longest branch in each of the three
phylogenies indicating that this branch may represent the most
ancestral form, or, that evolution of CDT has accelerated along
the Yersinia lineage (Aguileta et al., 2009). If Yersinia does repre-
sent the most ancestral form of CDT, these phylogenetic analyses
would indicate that CDT originated in the γ-Proteobacteria and
was later horizontally transferred into the ε-Proteobacteria based
on the evolutionary relationships seen in 16S rRNA phyloge-
nies (Ciccarelli et al., 2006; Yarza et al., 2010). The factors that
restrict transfer of genes encoding the CDTs to only species of the
γ-Proteobacteria and the ε-Proteobacteria are not clear.
Inconsistencies between the phylogenies for each subunit of
CDT are most likely the result of instances of horizontal gene
transfer. The species of Yersinia represent the most apparent
examples. In the case of Y. ruckeri, CdtA shows more similarity
to the more recently diverged Haemophilus/Aggregatibacter and
Escherichia dominated clades. In Y. enterocolitica, CdtC shows a
closer relationship to the Haemophilus/Aggregatibacter clade than
to other Yersinia sequences. As a member of the γ-Proteobacteria,
the CdtB sequence of H. chejuensis is likely a result of horizon-
tal gene transfer. H. cinaedi represents an example of horizontal
gene transfer between two closely related genera. Phylogenetically,
CDT from H. cinaedi is more similar to the C. fetus II clade
than the Helicobacter clade. Although H. cinaedi was recently
reclassified as a Helicobacter species after initial classification as
a Campylobacter species (Vandamme et al., 1991), it would be
expected to bemost similar toH. bilis based on the 16S rRNAphy-
logeny (Solnick and Vandamme, 2001). An interesting example of
horizontal gene transfer within only one of the three CDT genes
was found for C. lari, which is broken into three distinct clades
for CdtC, while only a single clade with one outlier is observed in
both CdtA and CdtB.
Although absent from the CdtB phylogeny (Figure 2), both
Y. ruckeri and Y. bercovieri possess a homolog to CdtB; how-
ever, these Y. ruckeri and Y. bercovieri sequences shared only 30%
identity with Y. enterocolitica CdtB and were far below the cut-
offs used when searching the NCBI database with a reference set
of CDT sequences. The published genome of Hahella chejuensis
revealed the presence of highly divergent CdtA and CdtB subunits
that were most similar to those found in the Yersinia, but these
proteins were also excluded from the phylogenetic analyses due
to unreliability of their alignment to other CDT sequences. For
Helicobacter mastomyrinus and H. callitrichis, no sequenced ver-
sion of CdtA or CdtC was available. Sequences with similarities
to CdtA or CdtC were identified within the carboxyla-termini of
several Pseudomonas entomophila open reading frames. However,
these proteins also contained regions of greater than a hundred
additional residues lacking sequence similarity to either CdtA or
CdtC, and these sequences were excluded from the phylogenetic
analyses.
The CdtB sequence has also been detected in multiple vari-
ants of the APSE bacteriophage that apparently lack the genes
encoding either CdtA or CdtC (Moran et al., 2005). APSE are
lysogenic phages that have been found to infect “Canditatus
Hamiltonella defensa” which is a facultative endosymbiont of
numerous sap-feeding insects. The presence of APSE has been
linkedwith the aphid possessing increased resistance against para-
sitoid wasps (Oliver et al., 2005). Unlike S. enterica Typhi, no alter-
native receptor-binding subunits have been detected (Degnan and
Moran, 2008). While the method of delivery of CdtB originating
from APSE remains unknown, it has been proposed that the “Ca.
Hamiltonella defensa” type two secretion system, type three secre-
tion system, or lysis of intracellular endosymbiont cells may be
factors in delivery (Degnan andMoran, 2008). Evolutionarily, the
presence of CdtB on APSE phages provides both another exam-
ple of a vector to facilitate horizontal gene transfer as well as an
example of co-option of this toxin by a symbiont to provide a
better fitness advantage to its host.
The presence of a Salmonella clade in the CdtB phylogeny
led to a hypothesis of modularity between CdtB and receptor-
binding subunits (Spanò et al., 2008). The CdtB sequences found
within that clade do not adhere to the canonical association of
CdtA, CdtB, and CdtC found in other species. Instead, these CdtB
sequences are found in a small pathogenicity island associated
with homologs to the pertussis toxin receptor-binding subunits
A and B. Previous studies have hypothesized that these pertussis
toxin B-fragment homologs in S. enterica Typhi may functionally
substitute for CdtA and CdtC found in almost all other species
(Spanò et al., 2008). Interestingly, our analyses revealed the sub-
stitution of the pertussis toxin B-fragment homologs for the
canonical CdtA and CdtC subunits within the published genomes
of both S. enterica arizonae as well as S. bongeri. Additionally,
potential homologs to both pertussis subunits were found by
BLAST in E. coli and Y. enterocolitica; however, they were not
present in same configuration as is seen in Salmonella. Finally,
it is noteworthy that S. enterica arizonae possess distinct copies
of both “types” of CDTs. However, the predicted CdtB protein
sequence in the “canonical” cdtA/cdtB/cdtC operon is truncated
by over 100 amino acid residues.
Taken together, these phylogenetic analyses reveal the emer-
gence of distinct CDT subfamilies, characterized by a high degree
of sequence diversity existing among the three subunits. The
extent to which this sequence diversity reflects true functional
differences between CDTs is largely unexplored. However, as dis-
cussed below, several studies have recently hinted at striking
dissimilarities in the potencies of CDTs from several different
species, as well as the requirement for distinct host determinants
required for intoxication, suggesting that individual CDTs may
bind, enter, and traffic within host cells in fundamentally different
ways.
STRUCTURE AND FUNCTION OF CDTs
DO CDTs POSSESS AN AB-TOXIN ARCHITECTURE?
Intracellular-acting bacterial protein toxins generally possess a
two-component “AB” functional architecture (Blanke, 2006). The
B components facilitate toxin binding and uptake into sensi-
tive host cells, whereas the A components, which are typically
enzymes, act upon specific intracellular targets in a manner that
alters or disrupts normal cellular function. Several subclasses of
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AB toxins can be differentiated based on the number and/or
arrangement of the A and B subunits. Diphtheria toxin and exo-
toxin A from Pseudomonas aeruginosa are single-chain AB toxins,
whose A and B components are encoded within a single polypep-
tide that are ultimately separated following proteolysis and reduc-
tion of a bridging disulfide linkage. Cholera and pertussis toxins
are members of the AB5 subclass, characterized by either homo-
or hetero-B-fragment pentamers that assemble non-covalently
with the catalytic A fragments prior to secretion. Anthrax toxin
is a member of a third AB toxin subclass called the binary toxins,
comprising separately secreted A and B polypeptides that assem-
ble on the surface of mammalian cells. As discussed below, CDTs
may comprise a 4th subclass of AB intracellular-acting toxins.
SUBUNIT REQUIREMENTS FOR ACTIVITY
Several studies have indicated that CdtA, CdtB, and CdtC assem-
ble into a heterotrimeric complex (Lara-Tejero and Galan, 2001;
Saiki et al., 2001, 2004; Wising et al., 2002; Nesiæ et al., 2004;
Shenker et al., 2004; Cao et al., 2005, 2008; Nesic and Stebbins,
2005; Hu and Stebbins, 2006; Yamada et al., 2006). The maxi-
mal potency of CDTs on mammalian cells is generally believed to
require the involvement of all three subunits. In fact, several stud-
ies have reported that the presence of CdtA, CdtB, and CdtC are
absolutely required for Hd-CDT (Lara-Tejero and Galan, 2001;
Saiki et al., 2001), Aa-CDT (Wising et al., 2002; Nesiæ et al., 2004;
Shenker et al., 2004), and Cj-CDT (Saiki et al., 2004; Cao et al.,
2005; Nesic and Stebbins, 2005) to induce cell cycle arrest within
intoxicated cells.
In contrast, several studies have indicated that CdtA is not
absolutely required for CDT activity. Mixtures of Aa-CdtB/Aa-
CdtC retained the capacity to induce G2/M cell cycle arrest in
the absence of Aa-CdtA (Cao et al., 2005, 2008; Hu and Stebbins,
2006; Yamada et al., 2006). Similarly, mixtures of recombinant
Hd-CdtB and Hd-CdtC induced cell elongation characteristic
of CDT-intoxicated cells, although the activity was enhanced in
the presence of periplasmic extracts containing Hd-CdtA (Deng
et al., 2001). In another study, whole-cell sonicates produced from
mutant strains ofH. ducreyi lacking the cdtB or cdtC genes exhib-
ited a loss of cytotoxic activity toward HeLa cells, whereas the
sonicate from the cdtA mutant retained cytotoxic activity, albeit
at a slightly reduced level (Lewis et al., 2001). For Cj-CDT, combi-
nations of recombinant CdtB and CdtC were only approximately
4-times less potent that mixtures of all three subunits in their
capacity to induce cell cycle arrest (Lee et al., 2003).
A more thorough understanding of the specific contributions
of the CdtA or CdtC subunits to the potency and action of
CDT holotoxins will require the systematic comparison of quan-
titative dose response curves derived from binary combinations
of CDT subunits versus those derived from the corresponding
heterotrimeric toxin assemblies.
EVIDENCE THAT CdtB IS THE INTRACELLULAR-ACTIVE FRAGMENT
OF CDT
The first indications that CDTs function as intracellular-acting
toxins were studies reporting that the cell cycle modulatory activ-
ity of Hd-CDT is inhibited when clathrin-mediated endocytosis is
blocked (Cortes-Bratti et al., 2000), suggesting that the toxinmust
be internalized from the cell surface into cells to induce G2/M
cell cycle arrest. Additional evidence for an intracellular site of
action came from transient expression or microinjection (Lara-
Tejero and Galan, 2000) of Cj-CdtB, or electroporation (Elwell
et al., 2001) of Ec-CdtB alone in mammalian cells, suggesting
the enzymatic activity resides within the CdtB subunit of the
holotoxin. Moreover, expression of Cj-CdtB alone in yeast also
induced G2/M arrest (Hassane et al., 2001), analogous to what
happens in mammalian cells. Using in vitro DNA degradation
assays, two groups demonstrated independently that CdtBs from
either E. coli and C. jejuni possess DNase I activity (Elwell and
Dreyfus, 2000; Lara-Tejero and Galan, 2000). Mutations in CdtB
residues predicted to be functionally equivalent to those in type
I DNases required for catalysis or magnesium-binding ablated
DNase activity (Elwell and Dreyfus, 2000; Lara-Tejero and Galan,
2000).
Interestingly, several studies have reported intracellular toxin
activity associated with the CdtC subunit. CdtC was necessary
for G2 arrest in human T cells that had been exposed to Aa-
CDT with a defective mutant form of the CdtB subunit (Shenker
et al., 2000). In addition, protein transfection of CHO cells with
recombinant forms of either Aa-CdtB or Aa-CdtC alone induced
cellular elongation and cell death (Mao and DiRienzo, 2002).
THE NUCLEUS AS THE SITE OF CDT ACTION
The capacity of CDT to induce cellular responses normally asso-
ciated with DNA damage suggests that the ultimate site of CdtB
action is the nucleus. In support of this model, the introduction of
Ec-CdtB directly into mammalian cells by either electroporation
or ectopic overexpression revealed enrichment of CdtB within
the nuclear region and G2/M cell cycle arrest (McSweeney and
Dreyfus, 2004). Mutant forms of the Ec-CdtB lacking putative
nuclear localization signals were deficient in nuclear localization
and the capacity to induce G2/M arrest (McSweeney and Dreyfus,
2004). For Aa-CdtB, deletion of a non-canonical amino-terminal
nuclear localization sequence prevented intoxication (Nishikubo
et al., 2003). Nonetheless, the capacity of the CdtB subunit to
localize to the nucleus of cells that have taken up holotoxin from
the cell surface remains to be demonstrated.
CdtB AS A DNase?
The discovery of Cj-CdtB (Lara-Tejero and Galan, 2000) and Ec-
CdtB (Elwell and Dreyfus, 2000) catalytic residues conserved with
eukaryotic DNase I, first suggested that this CDT subunit might
function as an intracellular-acting DNase. High resolution struc-
tural data support this idea, as structures for Hd-CdtB (Nesiæ
et al., 2004), Aa-CDT (Yamada et al., 2006), and Ec-CdtB (Hontz
et al., 2006) possess the canonical four-layered fold of the DNase
I family, which is a central 12-stranded β-sandwich packed
between outer α-helices and loops on each side of the sand-
wich. In vitro DNase I activity, albeit relatively poor, has been
demonstrated for purified CdtB subunits from several bacteria
(Elwell and Dreyfus, 2000). Directed mutagenesis of CdtB active
site residues predicted by sequence homology to be important
for the catalytic activity or the Mg2+-binding resulted in inactive
forms of CdtB deficient in DNA cleavage activity and in the capac-
ity to induce DNA damage responses leading to cell cycle arrest
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(Elwell and Dreyfus, 2000; Lara-Tejero and Galan, 2000; Hassane
et al., 2001; Guerra et al., 2005). In yeast, ectopic expression
of Cj-CdtB was demonstrated to induce homologous recombi-
nation and activation of DNA damage checkpoints, which are
characteristic mechanisms of cellular responses to DNA damage
(Kitagawa et al., 2007).
CDT AS A EUKARYOTIC-LIKE PHOSPHATASE?
There is not universal agreement that the cellular effects asso-
ciated with CDT intoxication are due to the DNA degrading
activity of the CdtB subunit. Indeed, sequence homology of CdtBs
with members of a broad metalloenzyme superfamily led to the
proposal that CdtB induces cell cycle arrest as a phosphatase
rather than a DNase (Dlakic, 2001). Support for this hypothesis
emerged from studies reporting that in vitro, Aa-CdtB demon-
strates PI-3,4,5-triphosphate phosphatase activity (Shenker et al.,
2007). Mutant proteins with altered residues known to be impor-
tant for phosphatase activity ablated the in vitro activity of Aa-
CdtB, as well as the capacity of Aa-holotoxin to induce G2/M
arrest in human lymphocytes.
To date, phosphatase activity has not been reported for any
CDT other than Aa-CDT. Several studies have reported data sug-
gesting that at least some of the cellular consequences of Aa-CDT
cellular intoxication are not likely due to phosphatase activity
of Aa-CdtB. Ectopic expression of Aa-CdtB in Saccharomyces
cerevisiae-induced DNA damage and S/G2 cell cycle arrest,
although yeast does not possess the substrate for the reported Aa-
CdtB phosphatidylinositol-3,4,5-triphosphate phosphatase activ-
ity (Matangkasombut et al., 2010). Moreover, Aa-CDT-mediated
apoptosis in proliferating U937 monocytes was demonstrated
to depend solely on the DNase activity of the Aa-CdtB subunit
(Rabin et al., 2009). The phosphatidylinositol-3,4,5-triphosphate
phosphatase activity is not likely to be idiosyncratic for Aa-CdtB,
as this subunit shares a nearly identical sequence to that of the
CdtB subunit from H. ducreyi (Hd-CdtB).
DO CdtA AND CdtC COLLABORATE AS THE B FRAGMENT OF CDT?
The cellular studies cited above strongly support the idea that
CdtB functions as the enzymatically active A component of an
intracellular-acting toxin. But what about CdtA and CdtC? The
canonical role of a toxin’s B component is to bind the toxin
to the cell surface and facilitate intracellular transport and/or
translocation of the catalytic A moiety out of the vesicle traf-
ficking network to access the toxins intracellular target (Blanke,
2006). As discussed above, there are conflicting reports as to the
essentiality of CdtA for toxin cellular activity, suggesting that
perhaps CdtC functions as the toxin B fragment. Indeed, this
notion is supported by independent reports of cellular cytotox-
icity associated with CdtB/CdtC alone (albeit requiring higher
concentrations than the tripartite holotoxin). However, the suf-
ficiency of CdtB/CdtC for cytolethal distending activity has not
been a universal finding. Moreover, reports of cellular cytotoxic-
ity associated with CdtC alone further muddy our understanding
of the structure and function of the CDTs.
High-resolution structural data have provided some clues,
with the CdtA and CdtC subunits of the Hd-CDT holotoxin bear-
ing structure homology with lectin-like proteins, including the
B-fragment repeats of the plant toxin, ricin (Nesiæ et al., 2004).
The importance of CdtA and CdtC for toxin binding and uptake
from the cell surface has directly been demonstrated in several
functional studies (Lee et al., 2003; McSweeney and Dreyfus,
2004, 2005). Fluorescence imaging indicated that Aa-CdtA alone
binds on the surface of CHO cells to the same extent as a mixture
of all three CDT subunits, and better than Aa-CdtB or Aa-CdtC
alone (Mao and DiRienzo, 2002). Cj-CDT was demonstrated to
bind to the surface of HeLa cells in a saturable manner (Lee et al.,
2003). The CdtA and CdtC subunits both bound to the surface
of HeLa cells, while CdtB demonstrated little binding to the cell
surface. Using a CELISA, the competition-binding assays revealed
that both CdtA and CdtC bound to the surface of cells in a specific
manner. However, defining the relative contributions of CdtA and
CdtC to binding CDT to the cell surface awaits additional study.
AN UNEXPECTED EXCEPTION TO THE CANONICAL CdtA/CdtB/CdtC
STRUCTURE
An interesting exception to the CdtA/CdtB/CdtC tripartite struc-
ture characteristic of the CDT superfamily was discovered within
S. enterica, serovar Typhi CDT (St-CDT) (Haghjoo et al., 2004),
for which the gene encoding CdtB is not associated with genes
resembling cdtA or cdtC. Instead, the cellular modulatory activ-
ity of St-CDT is dependent upon expression of two genes,
pltB (pertussis-like toxin B) and pltA (pertussis-like toxin A)
(Figure 1), which encode proteins resembling the B components
of pertussis toxin, an unrelated AB5-intracellular-acting toxin.
The reconstituted CdtB/PltA/PltB tripartite complex was demon-
strated to induce DNA damage within intoxicated eukaryotic
cells (Spanò et al., 2008). Infection studies revealed that bacterial
uptake into host cells triggers expression of cdtB/pltA/pltB, and
that the PltB and PltA subunits are required for transport of intra-
cellular St-CDT to the extracellular medium, where St-CDT then
acts upon uninfected host cells in a paracrine manner (Spanò
et al., 2008). Such a mechanism has not been previously described
for any AB-toxin, and suggests an expanded role beyond the
canonical functions normally associated with the B components
of intracellular-acting toxins.
MECHANISM OF CDT CELLULAR INTOXICATION
As intracellular-acting genotoxins, the CDTs have several fun-
damental problems to solve in order to exert their modulatory
activities, with the most glaring being how to transport soluble
CdtB moieties from the cell surface to the nucleus. There are
some recent indications, as discussed below, that host cell require-
ments for the genotoxic activity of CDTs from different species
may be divergent, raising the possibility that not all CdtBmoieties
travel from the cell surface to the nucleus along a single transport
pathway.
DO CDTs FLOAT INTO CELLS ON MEMBRANE RAFTS?
Cell surface binding and intoxication by several CDTs have been
reported to require toxin binding to cholesterol/sphingomyelin-
rich microdomains within the outer leaflet of the plasma mem-
brane called membrane rafts. Aa-CDT (Boesze-Battaglia et al.,
2006) binds to GM1-enriched regions of the plasma membrane,
which are characteristic of membrane rafts. Cholesterol depletion
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reduces the ability of both Aa-CDT (Boesze-Battaglia et al., 2006)
and Hd-CDT (Guerra et al., 2005) to bind to the surface of sensi-
tive cells, and prevents intoxication. Finally, mammalian cell lines
with an inactivated SGMS1 gene, resulting in reduced levels of
the key raft component sphingomyelin, were relatively resistant
to Ec-CDT (Carette et al., 2009). Although the functional sig-
nificance of CDT association with membrane rafts is not fully
appreciated, toxin bindingmay be important for uptake into cells,
as one of cellular functions associated with rafts is the clustering
of the molecular machinery associated with endocytosis.
CDT RECEPTORS—DOESONE SIZE FIT ALL?
The presence or absence of receptors on the plasma membrane
surface often dictates the sensitivity or resistance, respectively, of
host cells to specific intracellular-acting bacterial toxins (Blanke,
2006). Using ligand blotting assays, very early studies reported
the binding of partially purified Cj-CDT to two peptides with
approximate molecular masses of 45 and 59 kDa from HeLa cell
membrane preparations and 59 kDa from CHO cell membrane
preparations (Bag et al., 1993), suggesting the presence of molec-
ular components on the surface of host cells that might function
as CDT receptors.
To date, bonafide CDT receptors have not yet been identi-
fied. One study implicated fucose as an important determinant
for Ec-CDT, as lectins targeting fucose moieties-inhibited toxin
interactions with cells to a greater extent than lectins target-
ing alternative glycans (McSweeney and Dreyfus, 2005). Another
study indicated that the Aa-CDT holotoxin binds to surface
glycosphingolipids, and that inhibitors of glycosphingolipid syn-
thesis can prevent intoxication of the humanmonocytic U937 cell
line (Mise et al., 2005). Mutagenesis of a human cell line hap-
loid for most chromosomes identified cell lines deficient in the
membrane-expressed protein TMEM181 that were resistant to
Ec-CDT, although it is not yet clear that TMEM181 functions as
a cell surface receptor for this toxin (Carette et al., 2009).
A recent study in which Aa-CDT, Cj-CDT, Ec-CDT, and
Hd-CDT were compared in a head to head fashion revealed
considerable differences in the potencies of these toxins, as
well as the target cell requirements important for intoxication
(Eshraghi et al., 2010). For example, cholesterol was found to
be important for the cellular activities of Aa-CDT, Cj-CDT, and
Hd-CDT, but not for those of Cj-CDT. Using mutant CHO
cell lines lacking N-linked complex- or hybrid-carbohydrates,
glycosphingolipids, or fucose, the study also reported the unex-
pected finding that, N- and O-glycan, or fucosylated struc-
tures are in fact not required for mediating toxin binding
(Eshraghi et al., 2010). The diversity of cell surface determi-
nants important for CDT interactions identified in these early
studies suggest that individual CDTs may each bind to a dif-
ferent receptor. It is attractive to speculate that CDT receptor
diversity reflects the tissue tropism of individual CDT-producing
pathogens.
RIDING THE RAIL: CDT UPTAKE INTO HOST CELLS
Receptor-binding not only concentrates toxins on the surface of
host cells, but also positions bound toxin molecules to exploit
existing cellular mechanisms for uptake of proteins into cells
(Blanke, 2006). Several studies indicate that CDTs are rapidly
taken up from the cell surface into an intracellular compartment,
suggesting that these toxins are internalized by an endocytic-
like mechanism. In support of this idea, Hd-CDT-mediated cell
cycle arrest was demonstrated to be dependent on dynamin
(Cortes-Bratti et al., 2000), which contributes to several overall
mechanisms of endocytosis.
RETROGRADE TRAFFICKING TO THE ENDOPLASMIC RETICULUM (ER)
For CDT to function as a genotoxin, the CdtB subunit must
escape degradation within the endocytic trafficking pathway and
localize to the nucleus. Biochemical and fluorescence imaging
studies suggest that CDTs are transported in a retrograde man-
ner from the endo-lysosomal system to the ER via the Golgi
complex (Guerra et al., 2005) (Figure 3). Analogous to several
other toxins, including cholera and Shiga toxins, the catalyti-
cally active subunit (CdtB) is believed to be translocated from
the ER to the cytosol by exploiting the ER degradation pathway,
which normally translocates misfolded proteins to the cytosol
via protein translocons within the ER membrane (Blanke, 2006).
One study reported that Hd-CdtB was not detected within the
cytosol of intoxicated cells (Guerra et al., 2009). In fact, to
date, there is no experimental evidence that any CDT sub-
unit is translocated from the ER to the cytosol of intoxicated
cells, leading to the suggestion that the CdtB subunits may be
translocated directly from the ER to the nucleus (Guerra et al.,
2009).
Clearly, a major gap in the mechanism underlying CDT-
mediated cellular intoxication is how CdtB reaches its site of
action. As discussed above, the putative nuclear localization sig-
nals identified for two members of the CDT family, Aa-CDT and
Ec-CDT, are highly divergent, suggesting that the mechanisms by
which these two toxins are transported to the nucleus are not
necessarily identical.
MODULATION OF CELLULAR SIGNALING WITHIN
CDT-INTOXICATED CELLS
The designation of CDT as a genotoxin derives from the
demonstration that isolated CdtB (1) functions as a DNase
in vitro (Elwell and Dreyfus, 2000; Lara-Tejero and Galan, 2000),
(2) induces nuclear fragmentation and chromatin disruption
when transfected in cultured mammalian cells or Saccharomyces
cerevisae (Hassane et al., 2001), and, (3) promotes DNA fragmen-
tation in cells intoxicated with exogenously added CDT (Frisan
et al., 2003). CDT-mediated insults to genome integrity induces
cellular responses geared toward the repair of DNA lesions and
cell survival.
ACTIVATION OF DNA REPAIR RESPONSES
Most (yet not all) of the experimental evidence to date suggests
that the cellular modulatory activity of CDTs originates from
toxin-mediated DNA damage, which activates the cellular DNA
repair machinery. CDT-dependent DNA damage induces the
recruitment of the DNA damage sensor complex MRN and the
ATM kinase, which phosphorylates H2AX, a member of the his-
tone 2A family, and activation of several DNA damage checkpoint
responses. Several studies have demonstrated that activation of
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FIGURE 3 | Host cell surface binding and internalization of CDT. CDT binds
to a cell surface determinant, and in some cases, is affected by perturbations
in lipid rafts. Following internalization by clathrin-coated pits to the
endosomes, CDT is trafficked in a retrograde fashion to the Golgi-apparatus,
and the endoplasmic reticulum (ER). From the ER, CdtB localizes to the
nucleus by a yet unconfirmed route directly, or through the cytoplasm.
Experimental techniques used to identify the pathway employed by CDT to
trafficking inside the cell, are represented next to the organelles involved.
kinase CHK2 leads to inactivation of the CDC25 phosphatase,
resulting in the accumulation of the hyperphosphorylated (and
inactive) form of the cyclin-dependent kinase CDK1 (pCDK1),
leading ultimately to arrest at the G2/M interface (Sert et al.,
1999; Cortes-Bratti et al., 2001; Li et al., 2002; Sato et al., 2002;
Yamamoto et al., 2004; Cuevas-Ramos et al., 2010), and in some
cases, transition into a senescent state (Blazkova et al., 2010).
A second consequence of CDT-dependent DNA damage is acti-
vation of the tumor suppressor p53 and its downstream effec-
tor p21, leading to cell cycle arrest at the G1/S checkpoint in
this case.
CASHING IT IN? APOPTOSIS IN CDT-INTOXICATED CELLS
CDT-dependent apoptosis has been reported in many cell types.
In general, CDT intoxication of cells of non-haematopoietic
origin results in cell cycle arrest preceding apoptosis (Jinadasa
et al., 2011). In contrast, CDT intoxication of haematopoietic
cells results in rapid apoptosis, indicating differential cellular
responses to the action of CDTs.
ACTIVATION OF CELL SURVIVAL RESPONSES
While CDT-intoxicated cells have been demonstrated to undergo
apoptosis, there are reports that in some cases, CDTs also
mobilize cell survival pathways. The survival of CDT intox-
icated cells is dependent on the activation of the small
GTPase RhoA (Frisan et al., 2003), which induces actin stress
fiber formation, and prevents cell death via activation of the
mitogen-activated protein kinase p38 and its downstream tar-
get mitogen-activated protein kinase-activated protein kinase 2
(Guerra et al., 2008). The activation of RhoA is depen-
dent on the dephosphorylation of the RhoA-specific guanine
nucleotide exchange factor Net1, and it appears to be part of the
DNA damage repair responses because it requires a functional
ATM (Guerra et al., 2008).
COULD THE GENOTOXIC ACTION OF CDT INCREASE THE
RISK FOR CANCER WITHIN THE HOST?
Factors that disrupt normal cell cycle progression may promote
acquisition of the cancerous phenotype. While CDT clearly is
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a modulator of the cell cycle, does the action of this genotoxin
during infection contribute to the development of a cancerous
phenotype?
DEVELOPMENT OF PATHOGEN-MEDIATED INFLAMMATORY
MICROENVIRONMENTS
Infection with pathogenic bacteria has increasingly been associ-
ated with malignant disease in humans. However, when consid-
ering putative risk factors for cancer, the leap from association to
causality can be perilous. Howmight persistent bacterial infection
increase cancer risk? The evolution of pre-malignant to cancerous
cells is often characterized by a “mutator phenotype” in which
mutations accumulate at an accelerated rate, resulting in genomic
instability (Raptis and Bapat, 2006). One of the ways that bacte-
rial infections are thought to promote acquisition of the mutator
phenotype is the establishment of a chronic pro-inflammatory
microenvironment.
How might persistent bacterial infections induce inflamma-
tory microenvironments? During chronic infection, host tis-
sues are constantly exposed to bacterial PAMPs, which are
sensed by pattern recognition receptors (e.g., Toll-like receptors)
(Grivennikov et al., 2010). Sustained activation of pattern recog-
nition receptors results in elevated levels of pro-inflammatory
cytokines, as well as reactive oxygen species (ROS) and reactive
nitrogen intermediates (RNI), which are genotoxic agents that
increase the rate and incidence of mutations (Vogelmann and
Amieva, 2007).
The most extensively studied association of pathogen-
dependent establishment of pro-inflammatory microenviron-
ments and cancer is the increased risk of gastric adenocarcinoma
in those individuals infected with H. pylori (Polk and Peek,
2010). Notably, chronic H. pylori infection correlate with
a significant (5-fold) increase in mutation frequency and
microsatellite instabilities within the gastric epithelium of
infected mice (Touati et al., 2003). Other examples are chronic
carriage of S. enterica, serovar Typhi, and Bacteroides frag-
ilis, which have been associated with gallbladder and colon
cancers, respectively (Toprak et al., 2006; Vogelmann and
Amieva, 2007). Moreover, Streptococcus bovis with colon can-
cer, Chlamydia pneumoniae with lung cancer, and Bartonella
species with vascular tumor formation (Vogelmann and Amieva,
2007).
WHENCE CDTs AND MALIGNANCIES?
The contributions, if any, of CDTs to the development of human
malignancies are largely unexplored. Analogous to genotoxic
agents such as ROS and RNI that increase the rate of muta-
tions within the genome (Karin et al., 2006; Grivennikov et al.,
2010), one possibility is that CDT might contribute to pro-
gressive genome destabilization within the pathogen-induced
pro-inflammatorymicroenvironments (Grivennikov et al., 2010).
CDT activation of survival responses in cells harboring DNA
damage could contribute to the accumulation of genetic insta-
bility within the developing inflammatory micro-environment,
which may constitute the perfect storm of conditions for promot-
ing the transformation of pre-neoplastic cells to malignant cells
in the host.
Several studies have begun to address whether infection with
CDT-producing pathogenic bacteria may induce changes in the
host associated with an early neoplastic process. Using NF-κB-
deficient mice to study persistent C. jejuni infection, one study
indicated a proinflammatory role for Cj-CDT in vivo, as toxin-
producing strains were associated with significantly enhanced
severity of gastritis and significantly higher occurrence of gas-
tric hyperplasia and dysplasia, which are markers of an early
neoplastic process (Fox et al., 2004). For Helicobacter hepati-
cus, which causes chronic hepatitis and typhlocolitis in some
mice, CDT was demonstrated to be critical for persistent infec-
tion of Swiss Webster mice, which is characterized with severe
inflammation (Ge et al., 2005). In another study, H. hepati-
cus infection of A/JCr mice demonstrated a significantly higher
inflammatory response in strains producing Hh-CDT than iso-
genic mutant strains. (Ge et al., 2007). The presence of CDT was
associated with a progression of inflammation to dysplasia. In the
future, it will be important to conduct studies that will evalu-
ate potential associations between CDT-dependent dysplasia and
toxin-mediated DNA damage, chronic induction of DNA damage
repair pathways, and the acquisition of the type of genomic insta-
bility preceding acquisition of the mutator phenotype discussed
above.
ON TO THE FUTURE . . .
One cannot help but be fascinated by the vertical transmission
of phenotypic traits within families that can result in strikingly
similar appearance and mannerisms. But, as is often the case
when we dig below the surface, interesting and important dif-
ferences emerge which define the unique identity of individual
family members.
When considering the “CDT family,” a natural focus has
centered on the similarities among the individual members,
and to figure out, in essence, how they “look alike.” Most
of the excellent work that has been conducted thus far, by
many different laboratories, to identify and characterize the
structure-function relationships and intoxication properties has
appropriately focused on just several CDTs (e.g., Aa-CDT,
Cj-CDT, Ec-CDT, and Hd-CDT). The conclusions from study-
ing this small subset of the CDT family have been extended
rather generically across the broader family of CDTs. Yet, nei-
ther the structure-function relationships nor the mechanisms
underlying cellular intoxication of cells by the vast majority
of CDTs have been examined. In fact, the striking diversity
in the sequences of CDT subunits identified in an increas-
ing number of genomes of bacterial species from the γ-
Proteobacteria and ε-Proteobacteria suggest that the extent to
which individual CDTs function in a similar fashion should be
reexamined.
The degree to which the large sequence diversity among
CDTs reflects functional differences between individual mem-
bers of the CDT family is largely unexplored. Nonetheless,
as discussed above, there are some hints from several recent
studies that CDTs may in fact be highly divergent in their
potencies and specific host requirements for intoxication. It
will be interesting to test the premise that the functional
differences between CDTs may reflect the diversity of host
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cells and tissues that compromise the infection microenviron-
ments targeted by CDT-producing pathogenic bacteria.
One of the true challenges in the CDT field is to understand
the in vivo consequences of CDT action during infection. Studies
to understand, from an evolutionary perspective, the benefit of
CDT-mediated genotoxicity for promoting host-pathogen inter-
actions, remain a particular challenge, because any benefits may
in fact be highly idiosyncratic to the specific pathogen and the
host niche occupied by that pathogen.
ACKNOWLEDGMENTS
We acknowledge research support (NIH R01 GM0908756). We
offer our apologies to those investigators whose work we were
unable to cite.
REFERENCES
Aguileta, G., Refrégier, G., Yockteng,
R., Fournier, E., and Giraud, T.
(2009). Rapidly evolving genes in
pathogens: methods for detecting
positive selection and examples
among fungi, bacteria, viruses
and protists. Infect. Genet. Evol. 9,
656–670.
Bag, P. K., Ramamurthy, T., and Nair,
U. B. (1993). Evidence for the pres-
ence of a receptor for the cyto-
lethal distending toxin (CLDT) of
Campylobacter jejuni on CHO and
HeLa cell membranes and develop-
ment of a receptor-based enzyme-
linked immunosorbent assay for
detection of CLDT. FEMSMicrobiol.
Lett. 114, 285–291.
Blanke, S. R. (2006). Portals and path-
ways: principles of bacterial toxin
entry into host cells. Microbe 1,
26–32.
Blazkova, H., Krejcikova, K., Moudry,
P., Frisan, T., Hodny, Z., and Bartek,
J. (2010). Bacterial intoxication
evokes cellular senescence with per-
sistent DNA damage and cytokine
signalling. J. Cell. Mol. Med. 14,
357–367.
Boesze-Battaglia, K., Besack, D.,
McKay, T., Zekavat, A., Otis,
L., Jordan-Sciutto, K., et al.
(2006). Cholesterol-rich membrane
microdomains mediate cell cycle
arrest induced by Actinobacillus
actinomycetemcomitans cytolethal-
distending toxin. Cell Microbiol. 8,
823–836.
Cao, L., Bandelac, G., Volgina, A.,
Korostoff, J., and DiRienzo, J. M.
(2008). Role of aromatic amino
acids in receptor binding activ-
ity and subunit assembly of the
cytolethal distending toxin of
Aggregatibacter actinomycetem-
comitans. Infect. Immun. 76,
2812–2821.
Cao, L., Volgina, A., Huang, C. M.,
Korostoff, J., and DiRienzo, J. M.
(2005). Characterization of point
mutations in the cdtA gene of
the cytolethal distending toxin
of Actinobacillus actinomycetem-
comitans. Mol. Microbiol. 58,
1303–1321.
Carette, J. E., Guimaraes, C. P.,
Varadarajan, M., Park, A. S.,
Wuethrich, I., Godarova, A., et al.
(2009). Haploid genetic screens in
human cells identify host factors
used by pathogens. Science 326,
1231–1235.
Ciccarelli, F. D., Doerks, T., Von
Mering, C., Creevey, C. J., Snel, B.,
and Bork, P. (2006). Toward auto-
matic reconstruction of a highly
resolved tree of life. Science 311,
1283–1287.
Cortes-Bratti, X., Chaves-Olarte, E.,
Lagergård, T., and Thelestam, M.
(2000). Cellular internalization of
cytolethal distending toxin from
Haemophilus ducreyi. Infect. Immun.
68, 6903–6911.
Cortes-Bratti, X., Karlsson, C.,
Lagergard, T., Thelestam, M.,
Frisan, T., and Lagergård, T. (2001).
The Haemophilus ducreyi cytolethal
distending toxin induces cell cycle
arrest and apoptosis via the DNA
damage checkpoint pathways. J.
Biol. Chem. 276, 5296–5302.
Cuevas-Ramos, G., Petit, C. R., Marcq,
I., Boury, M., Oswald, E., and
Nougayrède, J. P. (2010). Escherichia
coli induces DNA damage in vivo
and triggers genomic instability in
mammalian cells. Proc. Natl. Acad.
Sci. U.S.A. 107, 11537–11542.
Degnan, P. H., and Moran, N. A.
(2008). Diverse phage-encoded tox-
ins in a protective insect endosym-
biont. Appl. Environ. Microbiol. 74,
6782–6791.
Deng, K., Latimer, J. L., Lewis, D.
A., and Hansen, E. J. (2001).
Investigation of the interaction
among the components of the
cytolethal distending toxin of
Haemophilus ducreyi. Biochem.
Biophys. Res. Commun. 285,
609–615.
Dlakic, M. (2001). Is CdtB a nuclease or
a phosphatase? Science 291, 547.
Elwell, C., Chao, K., Patel, K., and
Dreyfus, L. (2001). Escherichia coli
CdtBmediates cytolethal distending
toxin cell cycle arrest. Infect. Immun.
69, 3418–3422.
Elwell, C. A., and Dreyfus, L. A. (2000).
DNase I homologous residues in
CdtB are critical for cytolethal dis-
tending toxin-mediated cell cycle
arrest. Mol. Microbiol. 37, 952–963.
Eshraghi, A., Maldonado-Arocho,
F. J., Gargi, A., Cardwell, M. M.,
Prouty, M. G., Blanke, S. R., et al.
(2010). Cytolethal distending
toxin family members are dif-
ferentially affected by alterations
in host glycans and membrane
cholesterol. J. Biol. Chem. 285,
18199–18207.
Fox, J. G., Rogers, A. B., Whary, M.
T., Ge, Z., Taylor, N. S., Xu, S.,
et al. (2004). Gastroenteritis in NF-
kappaB-deficient mice is produced
with wild-type Camplyobacter
jejuni but not with C. jejuni lack-
ing cytolethal distending toxin
despite persistent colonization with
both strains. Infect. Immun. 72,
1116–1125.
Frisan, T., Cortes-Bratti, X., Chaves-
Olarte, E., Stenerlow, B., and
Thelestam, M. (2003). The
Haemophilus ducreyi cytolethal
distending toxin induces DNA
double-strand breaks and promotes
ATM-dependent activation of
RhoA. Cell Microbiol. 5, 695–707.
Ge, Z., Feng, Y., Whary, M. T., Nambiar,
P. R., Xu, S., Ng, V., et al. (2005).
Cytolethal distending toxin is
essential for Helicobacter hepaticus
colonization in outbred Swiss
Webster mice. Infect. Immun. 73,
3559–3567.
Ge, Z., Rogers, A. B., Feng, Y., Lee, A.,
Xu, S., Taylor, N. S., et al. (2007).
Bacterial cytolethal distending toxin
promotes the development of dys-
plasia in a model of microbially
induced hepatocarcinogenesis. Cell.
Microbiol. 9, 2070–2080.
Grivennikov, S. I., Greten, F. R.,
and Karin, M. (2010). Immunity,
inflammation, and cancer. Cell 140,
883–899.
Guerra, L., Carr, H. S., Richter-
Dahlfors, A., Masucci, M. G.,
Thelestam, M., Frost, J. A., et al.
(2008). A bacterial cytotoxin identi-
fies the RhoA exchange factor Net1
as a key effector in the response to
DNA damage. PLoS ONE 3:e2254.
doi: 10.1371/journal.pone.0002254
Guerra, L., Nemec, K. N., Massey,
S., Tatulian, S. A., Thelestam, M.,
Frisan, T., et al. (2009). A novel
mode of translocation for cytolethal
distending toxin. Biochim. Biophys.
Acta 1793, 489–495.
Guerra, L., Teter, K., Lilley, B. N.,
Stenerlow, B., Holmes, R. K.,
Ploegh, H. L., et al. (2005). Cellular
internalization of cytolethal dis-
tending toxin: a new end to a
known pathway. Cell Microbiol. 7,
921–934.
Haghjoo, E., Galan, J. E., and Galán, J.
E. (2004). Salmonella typhi encodes
a functional cytolethal distending
toxin that is delivered into host cells
by a bacterial-internalization path-
way. Proc. Natl. Acad. Sci. U.S.A.
101, 4614–4619.
Hassane, D. C., Lee, R. B., Mendenhall,
M. D., and Pickett, C. L. (2001).
Cytolethal distending toxin demon-
strates genotoxic activity in a
yeast model. Infect. Immun. 69,
5752–5759.
Hontz, J. S., Villar-Lecumberri, M.
T., Potter, B. M., Yoder, M. D.,
Dreyfus, L. A., and Laity, J. H.
(2006). Differences in crystal and
solution structures of the cytolethal
distending toxin B subunit: rele-
vance to nuclear translocation and
functional activation. J. Biol. Chem.
281, 25365–25372.
Hu, X., and Stebbins, C. E. (2006).
Dynamics and assembly of the cyto-
lethal distending toxin. Proteins 65,
843–855.
Jinadasa, R. N., Bloom, S. E., Weiss,
R. S., and Duhamel, G. E. (2011).
Cytolethal distending toxin: a
conserved bacterial genotoxin
that blocks cell cycle progression,
leading to apoptosis of a broad
range of mammalian cell lineages.
Microbiology 157, 1851–1875.
Johnson, W. M., and Lior, H. (1988a).
A new heat-labile cytolethal dis-
tending toxin (CLDT) produced by
Escherichia coli isolates from clin-
ical material. Microb. Pathog. 4,
103–113.
Johnson, W. M., and Lior, H. (1988b).
A new heat-labile cytolethal dis-
tending toxin (CLDT) produced by
Campylobacter spp. Microb. Pathog.
4, 115–126.
Karin, M., Lawrence, T., and Nizet,
V. (2006). Innate immunity gone
awry: linking microbial infections to
chronic inflammation and cancer.
Cell 124, 823–835.
Kitagawa, T., Hoshida, H., and Akada,
R. (2007). Genome-wide analysis of
cellular response to bacterial geno-
toxin CdtB in yeast. Infect. Immun.
75, 1393–1402.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org October 2012 | Volume 2 | Article 124 | 10
Gargi et al. Diversity among the CDTs
Lara-Tejero, M., and Galan, J. E. (2000).
A bacterial toxin that controls cell
cycle progression as a deoxyribonu-
clease I-like protein. Science 290,
354–357.
Lara-Tejero, M., and Galan, J. E. (2001).
CdtA, CdtB, and CdtC form a tri-
partite complex that is required for
cytolethal distending toxin activity.
Infect. Immun. 69, 4358–4365.
Lee, R. B., Hassane, D. C., Cottle,
D. L., and Pickett, C. L. (2003).
Interactions of Campylobacter jejuni
cytolethal distending toxin subunits
CdtA and CdtC with HeLa cells.
Infect. Immun. 71, 541–545.
Lewis, D. A., Stevens, M. K., Latimer,
J. L., Ward, C. K., Deng, K., Blick,
R., et al. (2001). Characterization
of Haemophilus ducreyi cdtA, cdtB,
and cdtC mutants in in vitro and
in vivo systems. Infect. Immun. 69,
5626–5634.
Li, L., Sharipo, A., Chaves-Olarte,
E., Masucci, M. G., Levitsky, V.,
Thelestam, M., et al. (2002). The
Haemophilus ducreyi cytolethal dis-
tending toxin activates sensors of
DNA damage and repair com-
plexes in proliferating and non-
proliferating cells. Cell Microbiol. 4,
87–99.
Mao, X., and DiRienzo, J. M. (2002).
Functional studies of the recombi-
nant subunits of a cytolethal dis-
tending holotoxin. Cell Microbiol. 4,
245–255.
Matangkasombut, O., Wattanawara-
porn, R., Tsuruda, K., Ohara,
M., Sugai, M., and Mongkolsuk,
S. (2010). Cytolethal distending
toxin from Aggregatibacter acti-
nomycetemcomitans induces DNA
damage, S/G2 cell cycle arrest, and
caspase-independent death in a
Saccharomyces cerevisiae model.
Infect. Immun. 78, 783–792.
McSweeney, L. A., and Dreyfus, L. A.
(2004). Nuclear localization of the
Escherichia coli cytolethal distending
toxin CdtB subunit. Cell Microbiol.
6, 447–458.
McSweeney, L. A., and Dreyfus, L.
A. (2005). Carbohydrate-binding
specificity of the Escherichia coli
cytolethal distending toxin CdtA-
II and CdtC-II subunits. Infect.
Immun. 73, 2051–2060.
Mise, K., Akifusa, S., Watarai, S., Ansai,
T., Nishihara, T., and Takehara, T.
(2005). Involvement of ganglioside
GM3 in G(2)/M cell cycle arrest of
human monocytic cells induced by
Actinobacillus actinomycetemcomi-
tans cytolethal distending toxin.
Infect. Immun. 73, 4846–4852.
Moran, N. A., Degnan, P. H., Santos, S.
R., Dunbar, H. E., and Ochman, H.
(2005). The players in a mutualistic
symbiosis: insects, bacteria, viruses,
and virulence genes. Proc. Natl.
Acad. Sci. U.S.A. 102, 16919–16926.
Nesiæ, D., Hsu, Y., Stebbins, C. E.,
and Nesic, D. (2004). Assembly and
function of a bacterial genotoxin.
Nature 429, 429–433.
Nesic, D., and Stebbins, C. E. (2005).
Mechanisms of assembly and cel-
lular interactions for the bacterial
genotoxin CDT. PLoS Pathog. 1:e28.
doi: 10.1371/journal.ppat.0010028
Nishikubo, S., Ohara, M., Ueno,
Y., Ikura, M., Kurihara, H.,
Komatsuzawa, H., et al. (2003).
An N-terminal segment of the
active component of the bacterial
genotoxin cytolethal distending
toxin B (CDTB) directs CDTB into
the nucleus. J. Biol. Chem. 278,
50671–50681.
Ochman, H., Lawrence, J. G., and
Groisman, E. A. (2000). Lateral gene
transfer and the nature of bacterial
innovation. Nature 405, 299–304.
Oliver, K. M., Moran, N. A., and
Hunter, M. S. (2005). Variation in
resistance to parasitism in aphids is
due to symbionts not host geno-
type. Proc. Natl. Acad. Sci. U.S.A.
102, 12795–12800.
Pickett, C. L., Cottle, D. L., Pesci, E.
C., and Bikah, G. (1994). Cloning,
sequencing, and expression of the
Escherichia coli cytolethal distend-
ing toxin genes. Infect. Immun. 62,
1046–1051.
Polk, D. B., and Peek, R. M. (2010).
Helicobacter pylori: gastric cancer
and beyond. Nat. Rev. Cancer 10,
403–414.
Rabin, S. D. P., Flitton, J. G.,
and Demuth, D. R. (2009).
Aggregatibacter actinomycetem-
comitans cytolethal distending
toxin induces apoptosis in non-
proliferating macrophages by a
phosphatase-independent mecha-
nism. Infect. Immun. 77, 3161–3169.
Raptis, S., and Bapat, B. (2006). Genetic
instability in human tumors. EXS
96, 303–320.
Saiki, K., Gomi, T., and Konishi, K.
(2004). Deletion and purification
studies to elucidate the structure of
the Actinobacillus actinomycetem-
comitans cytolethal distending
toxin. J. Biochem. 136, 335–342.
Saiki, K., Konishi, K., Gomi, T.,
Nishihara, T., and Yoshikawa, M.
(2001). Reconstitution and purifi-
cation of cytolethal distending toxin
of Actinobacillus actinomycetem-
comitans. Microbiol. Immunol. 45,
497–506.
Sato, T., Koseki, T., Yamato, K., Saiki,
K., Konishi, K., Yoshikawa, M.,
et al. (2002). p53-independent
expression of p21(CIP1/WAF1) in
plasmacytic cells during G(2)
cell cycle arrest induced by
Actinobacillus actinomycetem-
comitans cytolethal distending
toxin. Infect. Immun. 70, 528–534.
Scott, D. A., and Kaper, J. B. (1994).
Cloning and sequencing of the
genes encoding Escherichia coli
cytolethal distending toxin. Infect.
Immun. 62, 244–251.
Sert, V., Cans, C., Tasca, C., Bret-
Bennis, L., Oswald, E., Ducommun,
B., et al. (1999). The bacterial cyto-
lethal distending toxin (CDT) trig-
gers a G2 cell cycle checkpoint
in mammalian cells without pre-
liminary induction of DNA strand
breaks. Oncogene 18, 6296–6304.
Shenker, B. J., Besack, D., McKay,
T., Pankoski, L., Zekavat, A.,
and Demuth, D. R. (2004).
Actinobacillus actinomycetem-
comitans cytolethal distending toxin
(Cdt): evidence that the holotoxin is
composed of three subunits: CdtA,
CdtB, and CdtC. J. Immunol. 172,
410–417.
Shenker, B. J., Dlakic, M., Walker, L.
P., Besack, D., Jaffe, E., LaBelle, E.,
et al. (2007). A novel mode of action
for a microbial-derived immuno-
toxin: the cytolethal distending
toxin subunit B exhibits phos-
phatidylinositol 3, 4, 5-triphosphate
phosphatase activity. J. Immunol.
178, 5099–5108.
Shenker, B. J., Hoffmaster, R. H.,
McKay, T. L., and Demuth, D. R.
(2000). Expression of the cytolethal
distending toxin (Cdt) operon
in Actinobacillus actinomycetem-
comitans: evidence that the CdtB
protein is responsible for G2 arrest
of the cell cycle in human T cells.
J. Immunol. 165, 2612–2618.
Solnick, J. V., and Vandamme,
P. (2001). Taxonomy of the
Helicobacter Genus. Helicobacter
pylori: Physiology and Genetics,
Chapter 5. Washington, DC: ASM
Press.
Spanò, S., Ugalde, J. E., and Galán, J.
E. (2008). Delivery of a Salmonella
typhi exotoxin from a host intra-
cellular compartment. Cell Host
Microbe 3, 30–38.
Toprak, N. U., Yagci, A., Gulluoglu, B.
M., Akin, M. L., Demirkalem, P.,
Celenk, T., et al. (2006). A possible
role of Bacteroides fragilis entero-
toxin in the aetiology of colorectal
cancer. Clin. Microbiol. Infect. 12,
782–786.
Touati, E., Michel, V., Thiberge, J.
M., Wuscher, N., Huerre, M.,
and Labigne, A. (2003). Chronic
Helicobacter pylori infections
induce gastric mutations in mice.
Gastroenterology 124, 1408–1419.
Vandamme, P., Falsen, E., Rossau,
R., Hoste, B., Segers, P., Tytgat,
R., et al. (1991). Revision of
Campylobacter, Helicobacter, and
Wolinella taxonomy: emendation of
generic descriptions and proposal
of Arcobacter gen. nov. Int. J. Syst.
Bacteriol. 41, 88–103.
Vogelmann, R., and Amieva, M.
R. (2007). The role of bacterial
pathogens in cancer. Curr. Opin.
Microbiol. 10, 76–81.
Wising, C., Svensson, L. A., Ahmed,
H. J., Sundaeus, V., Ahlman, K.,
Jonsson, I. M., et al. (2002). Toxicity
and immunogenicity of purified
Haemophilus ducreyi cytolethal dis-
tending toxin in a rabbit model.
Microb. Pathog. 33, 49–62.
Yamada, T., Komoto, J., Saiki, K.,
Konishi, K., and Takusagawa, F.
(2006). Variation of loop sequence
alters stability of cytolethal distend-
ing toxin (CDT): crystal structure
of CDT from Actinobacillus acti-
nomycetemcomitans. Protein Sci. 15,
362–372.
Yamamoto, K., Tominaga, K., Sukedai,
M., Okinaga, T., Iwanaga, K.,
Nishihara, T., et al. (2004). Delivery
of cytolethal distending toxin B
induces cell cycle arrest and apop-
tosis in gingival squamous cell
carcinoma in vitro. Eur. J. Oral Sci.
112, 445–451.
Yarza, P., Ludwig, W., Euzéby, J.,
Amann, R., Schleifer, K.-H.,
Glöckner, F. O., et al. (2010).
Update of the all-species living
tree project based on 16S and 23S
rRNA sequence analyses. Syst. Appl.
Microbiol. 33, 291–299.
Conflict of Interest Statement: The
authors declare that the research
was conducted in the absence of any
commercial or financial relationships
that could be construed as a potential
conflict of interest.
Received: 01 April 2012; accepted: 17
September 2012; published online: 08
October 2012.
Citation: Gargi A, Reno M, and Blanke
SR (2012) Bacterial toxin modulation of
the eukaryotic cell cycle: are all cytolethal
distending toxins created equally? Front.
Cell. Inf. Microbio. 2:124. doi: 10.3389/
fcimb.2012.00124
Copyright © 2012 Gargi, Reno and
Blanke. This is an open-access article
distributed under the terms of the
Creative Commons Attribution License,
which permits use, distribution and
reproduction in other forums, provided
the original authors and source are
credited and subject to any copyright
notices concerning any third-party
graphics etc.
Frontiers in Cellular and Infection Microbiology www.frontiersin.org October 2012 | Volume 2 | Article 124 | 11
